Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
1999-12-13
2002-11-26
Kunz, Gary L. (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007100, C435S325000, C435S364000, C435S365000, C435S366000, C435S252100, C435S254200, C530S350000
Reexamination Certificate
active
06485919
ABSTRACT:
The present invention relates to nucleic acids and receptor proteins encoded thereby. Invention nucleic acids encode novel human metabotropic glutamate receptor subtypes. The invention also relates to methods for making such receptor subtypes and for using the receptor proteins in assays designed to identify and characterize compounds which affect the function of such receptors, e.g., agonists, antagonists, and allosteric modulators of human metabotropic glutamate receptors.
BACKGROUND OF THE INVENTION
The amino acid L-glutamate is a major excitatory neurotransmitter in the mammalian central nervous system. Anatomical, biochemical and electrophysiological analyses suggest that glutamatergic systems are involved in a broad array of neuronal processes, including fast excitatory synaptic transmission, regulation of neurotransmitter releases, long-term potentiation, learning and memory, developmental synaptic plasticity, hypoxic-ischemic damage and neuronal cell death, epileptiform seizures, as well as the pathogenesis of several neurodegenerative disorders. See generally, Monaghan et al., Ann. Rev. Pharmacol. Toxicol. 29:365-402 (1980). This extensive repertoire of functions, especially those related to learning, neurotoxicity and neuropathology, has stimulated recent attempts to describe and define the mechanisms through which glutamate exerts its effects.
Currently, glutamate receptor classification schemes are based on pharmacological criteria. Glutamate has been observed to mediate its effects through receptors that have been categorized into two main groups: ionotropic and metabotropic. Ionotropic glutamate receptors contain integral cation-specific, ligand-gated ion channels, whereas metabotropic glutamate receptors are G-protein-coupled receptors that transduce extracellular ti signals via activation of intracellular second messenger systems. Ionotropic receptors are further divided into at least two categories based on the pharmacological and functional properties of the receptors. The two main types of ionotropic receptors are NMDA (N-methyl-D-aspartate) receptors and kainate/AMPA (&agr;-amino-3-hydroxy-5-methyl-4-isoxazole propionate, formerly called the quisqualic acid or QUIS receptor), receptors. While the metabotropic receptors bind to some of the same ligands that bind to ionotropic glutamate receptors, the metabotropic receptors alter synaptic physiology via GTP-binding proteins and second messengers such as cyclic AMP, cyclic GMP, diacylglycerol, inositol 1,4,5-triphosphate and calcium [see, for example, Gundersen et al., Proc. R. Soc. London Ser. 221:127 (1984); Sladeczek et al., Nature 317:717 (1985); Nicoletti et al., J. Neurosci. 6:1905 (1986); Sugiyama et al., Nature 325:531 (1987)].
The electrophysiological and pharmacological properties of metabotropic glutamate receptors have been studied using animal tissues and cell lines as a source of receptors, as well as non-human recombinant receptors. The value of such studies for application to the development of human therapeutics has been limited by the availability of only non-human receptors. Moreover, it is only recently that the characteristics and structure of metabotropic glutamate receptors have been investigated at the molecular level. Such investigation has, however, only been carried out in non-human species. Because of the potential physiological and pathological significance of metabotropic glutamate receptors, it is imperative (particularly for drug screening assays) to have available human sequences (i.e., DNA, RNA, proteins) which encode representative members of the various glutamate receptor classes. The availability of such human sequences will also enable the investigation of receptor distribution in humans, the correlation of specific receptor modification with the occurrence of various disease states, etc.
BRIEF DESCRIPTION OF THE INVENTION
The present invention discloses novel nucleic acids encoding human metabotropic glutamate receptor protein subtypes and the proteins encoded thereby. In a particular embodiment the novel nucleic acids encode full-length mGluR1, mGluR2, mGluR3 and mGluR5 subtypes of human metabotropic glutamate receptors, or portions thereof. In addition to being useful for the production of metabotropic glutamate receptor subtype proteins, these nucleic acids are also useful as probes, thus enabling those skilled in the art, without undue experimentation, to identify and isolate nucleic acids encoding related receptor subtypes.
In addition to disclosing novel metabotropic glutamate receptor protein subtypes, the present invention also comprises methods for using such receptor subtypes to identify and characterize compounds which affect the function of such receptors, e.g., agonists, antagonists, and modulators of glutamate receptor function. The invention also comprises methods for determining whether unknown protein(s) are functional as metabotropic glutamate receptor subtypes.
REFERENCES:
patent: 4837148 (1989-06-01), Cregg
patent: 4855231 (1989-08-01), Stroman et al.
patent: 4882279 (1989-11-01), Cregg
patent: 4929555 (1990-05-01), Cregg et al.
patent: 5024939 (1991-06-01), Gorman
patent: 5385831 (1995-01-01), Mulvihill et al.
patent: 6001581 (1999-12-01), Johnson et al.
patent: WO 92/02639 (1991-08-01), None
patent: WO 93/13423 (1992-12-01), None
Baskys A. Metabotropic receptors and ‘slow’ excitatory actions of glutamate agonists in the hippocampus. Trends Neurosci. 15:92-96, 1992.*
Abe et al., “Molecular Characterization of a Novel Metabotropic Glutamate Receptor mGluR5 Coupled to Inositol Phosphate/Ca2+Signal Transduction”Journal of Biological Chemistry267(19):13361-13368 (1992).
Bahouth et al., “Immunological approaches for probing receptor structure and function”TIPS Reviews12:338-343 (1991).
Biel et al., “Another member of the cyclic nucleotide-gated channel family, expressed in testis, kidney and heart”Procl Natl. Acad. Sci. USA91:3505-3509 (1994).
Brabet et al., “Phenylglycine Derivatives Discriminate Between mGluR1- and mGluR5-mediated Responses”Neuropharmacology34(8):895-903 (1995).
Bradford, Marion M., “A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding”Analytical Biochemistry72:248-254 (1976).
Bruno et al., “Activation of Metabotropic Glutamate Receptors Coupled to Inositol Phospholipid Hydrolysis Amplifies NMDA-induced Neuronal Degeneration in Cultured Cortical Cells”Neuropharmacology34(8):1089-1098 (1995).
Buisson and Choi, “The Inhibitory mGluR Agonist, s-4-carboxy-3-hydroxy-phenylglycine Selectively Attenuates DMDA Neurotoxicity and Oxygen-Glucose Deprivation-induced Neuronal Death”Neuropharmacology34(8):1081-1087 (1995).
Conquet, F., “Inactivation In Vivo of Metabotropic Glutamate Receptor I by Specific Chromosomal Insertion of Reporter Gene lacZ”Neuropharmacology34(8):865-870 (1995).
Daggett et al., “Molecular and Functional Characterization of Recombinant Human Metabotropic Glutamate Receptor Subtype 5”Neuropharmacology34(8):871-886 (1995).
Dani and Mayer, “Structure and function of glutamate and nicotinic acetylcholine receptors”Current Opinion in Neurobiology5:310-317 (1995).
Dascal, Nathan, “The Use of Xenopus Oocytes for the Study of Ion Channels”CRC Critical Reviews in Biochemistry22(4):317-387 (1987).
Denhardt et al., “A Membrane-Filter Technique for the Detection of Complementary DNA”Biochemistry and Biophysical Research Communications23(5):641-646 (1966).
Dhallan et al., “Primary structure and functional expression of a cyclic nucleotide-activated channel from olfactory neurons”Nature347:184-187 (1990).
Felder et al., “A Transfected m1 Muscarinic Acetylcholine Receptor Stimulates Adenylate Cyclase via Phosphatidylinositol Hydrolysis”J. of Biol. Chem.264(34):20356-20362 (1989).
Fisher and Aronson, Jr., “Characterization of the cDNA and Genomic Sequence of a G Protein &ggr; Subunit (&ggr;5)”Molecular and Cellular Biol.12(4):1585-1591 (1992).
Gautam et al., “G protein diversity is increased by associations with a variety of &ggr; subunits”Proc. Na
Daggett Lorrie
Ellis Steven B.
Hess Stephen D.
Johnson Edwin C.
Liaw Chen
Kohli Vineet
Kunz Gary L.
Landsman Robert S.
Merck & Co. , Inc.
Tribble Jack L.
LandOfFree
Human metabotropic glutamate receptors, nucleic acids... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human metabotropic glutamate receptors, nucleic acids..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human metabotropic glutamate receptors, nucleic acids... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2963040